Advanced Search:
Equity Index

GENT.OL - GENTIAN DIAGNOSTIC

kr38.60  -0.6 (-1.53%)

Updated: 08:40 May 9, 2024 EST

Next Session's AI Forecast

98.61%

Avg. Accuracy (AI)

kr39.59

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

kr40.18

GENTIAN DIAGNOSTIC's Position Within the Medical Devices Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

GENTIAN DIAGNOSTIC - HISTORICAL DATA 6M

  • Last price

    kr38.60

  • Daily change

    kr-0.6

  • Previous Close

    kr39.2

  • Last Updated

    08:40 May 9, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0 0.4 -0.19 -0.04 -0.12

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.38 2.37 1.79 2.04 1.96

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 45% 56% 45.16%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
39.07 1.67% 38.43 1.29% 37.94 -4.6% 39.77

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
1.43 34.64 1.7 58.85

GENTIAN DIAGNOSTIC Technical Analysis News

GENTIAN DIAGNOSTIC

Bjørnåsveien 5
Moss 1596
Norway
47 99 33 99 05
https://www.gentian.com

Sectors: Healthcare
Industry: Medical Devices
F. Time Employees: 58
Description

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research worldwide. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a glomerular filtration rate marker for the diagnosis and therapeutic control of renal function; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and canine CRP immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. It also provides SARS-CoV-2 total antibody immunoassay, quantitative antibody test captures the full immune response detecting antibodies targeting the S1-subunit. In addition, the company develops NT-proBNP Immunoassay, an aid in the diagnosis, monitoring and assessment of severity in individuals suspected of having congestive heart failure which is in product development phase. Further, it offers faecal calprotectin immunoassay, provides results of calprotectin in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. The company was founded in 2001 and is headquartered in Moss, Norway.

Corporate Governance

Gentian Diagnostics ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.